cervical clear cell adenocarcinoma
cervical clear cell adenocarcinoma
Explore linked clinical trials. Standard reference: MONDO:00061351 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Lorigerlimab in Participants With Advanced Solid Tumors | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, cervical clear cell adenocarcinoma, endometrium neoplasm, fallopian tube clear cell adenocarcinoma, female reproductive system disorder, female reproductive system neoplasm, neoplasm, ovarian clear cell adenocarcinoma, uterine disorder | Recruiting | Phase 2 | 2026-06-02 | NCT06730347 |